No Detail Found!

Clinical spectrum and outcomes of cancer patients affected with COVID-19 in Indian population: A single- center retrospective study

Author(s)
Sonai Datta Kakati Department of Anesthesiology, Critical Care & Pain, Dr. B. Borooah Cancer Institute,Guwahati, Assam,India
Anupam Das Department of Anesthesiology, Critical Care & Pain, Dr. B. Borooah Cancer Institute,Guwahati, Assam,India
Marie Ninu Department of Anesthesiology, Critical Care & Pain, Dr. B. Borooah Cancer Institute,Guwahati, Assam,India
Barnali Kakati Department of Anesthesiology, Critical Care & Pain, Dr. B. Borooah Cancer Institute,Guwahati, Assam,India
Abstract
Introduction: Cancer patients affected with COVID-19 are at high risk of severe infection and death which depends upon their functional status, cancer type and treatment modality. In this study, we measured outcome by mortality and length of stay in hospital and intensive care unit, need of oxygen and respiratory assist devices and performance status after discharge. Methodology: This retrospective observational study was carried out in active cancer patients with confirmed positive RT-PCR for SARS-CoV-2 between April 2021 and August 2021. Patients with cancer treated more than 6 months back, those in remission and home isolation were excluded. Demographic profile, cancer type, staging and treatment, severity of COVID, treatment, oxygen supplementation, as well as ICU and hospital stay were analyzed. Statistical analysis was done using descriptive and inferential analysis. Significance was assessed at 5% level of significance. Chi-square/ Fisher Exact test was used to find the significance of the study parameters on categorical scale between two or more groups, non-parametric setting for qualitative data analysis. Fisher Exact test was used when cell samples were very small. P £ 0.01 was considered as strongly significant. Results: Out of 92 patients, there were 17 deaths (mortality 18.4%). Mortality was associated with cancer stage, comorbidities, severity of COVID symptoms, use of oxygen, high flow nasal cannula, non-invasive ventilation and decreased Eastern Cooperative Oncology Group score on discharge (P = 0.001). Age, raised C-reactive protein and D dimer levels were associated with increased severity of COVID-19. Conclusion: Cancer patients with COVID-19 have increased morbidity and mortality affected by various factors related either to pre-existent cancer or the newly acquired COVID-19. Abbreviations: CRP - C-reactive protein; ECOG - Eastern Cooperative Oncology Group score; RT-PCR - Reverse Transcriptase Polymerase Chain Reaction; HFNC - High Flow Nasal Cannula
Publication Details
Page(s) 506-512
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 27, Issue: 5, Year: 2023

Request the full text from PASTIC

Keywords
COVID-19, Critical illness, Neoplasms, Death, Covid-19, oxygen
References
Gao YD,Ding M,Dong X,Zhang JJ,Kursat Azkur A,Azkur D . .Risk factors for severe and critically ill COVID‐19 patients: a review. Allergy, 76(2) : 428-455.
Mohammadpour M,Yazdi H,Bagherifard A,Jabalameli M,Moghtadaei M,Torkaman A . .Evaluation of early complications, outcome, and mortality in Coronavirus Disease 2019 (COVID-19) infection in patients who underwent orthopedic surgery. 2022 Jan, 18(1) : 64.
Cottu P,Bozec L,Basse C,Paoletti X,Meta-Analysis X . .Re: Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review. J Natl Cancer Inst. 2021 Mar, 1(3) : 342-343.
Pagano L,Salmanton-García J,Marchesi F,Busca A,Corradini P,Hoenigl M . .-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). J Hematol Oncol. 2021 Oct, 14(1) : 168.
Hijano DR,Maron G,Hayden RT . .Respiratory Viral Infections in Patients With Cancer or Undergoing Hematopoietic Cell 1. , : .
Microbiol Transplant. Front .2018 .. 2018 Dec, 12 : 3097.
.2022 .Clinical management of COVID-19: living guideline, 15 September 2022. , : .
Assaad S,Zrounba P,Cropet C .2021 .ONCOVID-19 study Consortium; Blay JY. Mortality of patients with solid and haematological cancers presenting with symptoms of COVID-19 with vs without detectable SARS-COV-2: a French nationwide prospective cohort study. Br J Cancer, 125(5) : 658-671.
Saini KS,Tagliamento M,Lambertini M,McNally R,Romano M,Leone M .2020 .Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies. Eur J Cancer, 08 : 43-50.
Dai M,Liu D,Liu M,Zhou F,Li G,Chen Z .2020 .Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. Patients with Cancer in SARS-COV-2 Infection. , 20(6) : 2159-8290.
Assaad S,Avrillon V,Fournier ML,Mastroianni B,Russias B,Swalduz A .2020 .High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV2 on RT-PCR. Eur J Cancer, 05 : 251-259.
Kalinsky K,Accordino MK,Hosi K,Hawley JE,Trivedi MS,Crew KD .2020 .Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City. Breast Cancer Res Treat, 182(1) : 239-242.
Elkrief A,Desilets A,Papneja N,Cvetkovic L,Groleau C,Lakehal YA .2020 .High mortality among hospital-acquired COVID-19 infection in patients with cancer: a multicentre observational cohort study. Eur J Cancer, 08 : 181-187.
Liang W,Guan W,Chen R,Wang W,Li J,Xu K .2020 .Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol, 20(3) : 30096-6.
Zhang L,Zhu F,Xie L,Wang C,Wang J,Chen R .2020 .Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. , 03(7) : 894-901.
Ferrari BL,Ferreira CG,Menezes M,De Marchi P,Canedo J,Melo AC . .Determinants of COVID-19 Mortality in Patients With Cancer From a Community Oncology Practice in Brazil. JCO Glob Oncol. 2021 Jan;, 7 : 46-55.
Aboueshia M,Hussein MH,Attia AS,Swinford A,Miller P,Omar M .2021 .Cancer and COVID-19: analysis of patient outcomes. -0121, 17(26) : 3499-3510.
Sorouri M,Kasaeian A,Mojtabavi H,Radmard AR,Kolahdoozan S,Anushiravani A . .Clinical characteristics, outcomes, and risk factors for mortality in hospitalized patients with COVID-19 and cancer history: a propensity score-matched study. 2020 Dec, 17(1) : 74.
Yang K,Sheng Y,Huang C,Jin Y,Xiong N,Jiang K .2020 .Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol, 20(7) : 30310-7.
Garassino MC,Whisenant JG,Huang LC,Trama A,Torri V,Agustoni F .2020 .-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol, 20(7) : 30314-4.
Meng Y,Lu W,Guo E,Liu J,Yang B,Wu P . .Cancer history is an independent risk factor for mortality in hospitalized COVID19 patients: a propensity score-matched analysis. J Hematol Oncol. 2020 Jun, 10(1) : 75.
Han S,Zhuang Q,Chiang J,Tan SH,Chua GWY,Xie C . .Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis. 2022 Feb, 7(2) : e044661-044661.
0

Citations

0

Downloads

58

Views